Core B (Animal Component)
Core B (Animal Component)
批准号:
10421280
负责人:
JIANMING XU
金额:
$23.78万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2024-04-30
关键词:
Adipose tissueAnimal ExperimentsAnimal HusbandryAnimalsBreedingCRISPR/Cas technologyCaringCellsCollaborationsDNADataDiseaseEmbryoEmbryo TransferEquipmentFOXO1A geneFeeding behaviorsFemaleFertilization in VitroFosteringFunctional disorderFundingGene TargetingGenerationsGenesGenetically Engineered MouseGenotypeGuidelinesHomeostasisHumanHuman ResourcesHypothalamic structureInstitutesKnock-inKnock-outLiverMaintenanceMediatingMediator of activation proteinMessenger RNAMetabolicMetabolic DiseasesMetabolic PathwayMetabolismMethodologyMethodsMolecular TargetMusMutant Strains MiceNuclear ReceptorsOvulationPPAR alphaPPAR gammaPathway interactionsPhysiologicalProductionProgram EffectivenessProgram Research Project GrantsProtein IsoformsProteinsProtocols documentationRegulator GenesResearchResearch PersonnelResourcesRoleSTAT3 geneSavingsServicesSiteSystemTechnologyTherapeuticTimeTrainingTransgenesTransgenic MiceTransgenic OrganismsUnited States National Institutes of HealthVariantXBP1 geneanimal facilityanimal resourcebaseconditional knockoutcost effectivenessembryo cryopreservationembryonic stem cellexperienceexperimental analysisexperimental studygenotypic sexhomologous recombinationknock-downmalemouse genomemouse modelnuclear receptor coactivator 1operationoverexpressionpre-clinicalpreservationprogramssexsperm cryopreservationsuccesstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core B (Animal Component) - Project Summary
All research projects of this Program Project (PP) will rely on the use of genetically engineered mouse (GEM)
models to investigate the roles and mechanism of Nuclear Receptors, transcription factors and their coregulators
in energy and metabolic homeostasis and disease. More specifically, at least 34 GEM mouse lines will be used,
and thousands of male and female mice will be produced by breeding in house during the funding period of this
PP. Therefore, this Animal Component of Core B is essential for the success of this PP by integrating expensive
equipment, advanced technology, experienced personnel and animal resources. As shown by preliminary
studies, Core B has generated/established multiple GEM lines and developed CRISPR-Cas9-mediated mouse
gene editing systems. Core B is dedicated to achieving 3 major objectives. Firstly, Core B will use its specialized
expertise, state-of-the-art equipment and adequate facilities to generate GEM lines for all investigators of this
PP. Core B has established the necessary methods to edit the mouse genome by homologous recombination-
based gene targeting in ES cells or CRISPR/Cas9-based gene editing in 1-cell mouse embryos. Core B will
generate all GEM lines needed by the investigators of this PP. Secondly, Core B will provide high quality mouse
services to manage GEM line colonies and produce genotype-defined and age/sex-matched mice for all
investigators of this PP. Specifically, Core B will breed and maintain all of the 34 mouse lines used by this PP.
Core B will use our colony expansion protocol to produce large numbers of genotype/age/sex-matched mice for
experimental analysis. Core B also will perform genotype analysis, super ovulation, embryo and sperm
cryopreservation, and in vitro fertilization services to help the investigators of this PP for managing their mouse
colonies, preserving GEM lines, transferring mouse lines between institutes, and saving animal husbandry
expenses. Finally, Core B will integrate the efficient usage of animal resources by all investigators of this PP.
Because of the large-scale operation of mouse models and the sharing features of multiple mouse lines among
the projects of this PP, centralized integration of equipment, expertise and valuable mouse resource will be
essential for both scientific success and cost effectiveness. Core B will minimize the expenses of animal
experiments by consolidating the usage and management of equipment, expertise, animal facility, mouse
maintenance and production. In addition, Core B will serve as a resource for execution and technical training in
the use of all animal manipulations needed and oversee the care and use of experimental mice for this PP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The primary role of low NCOA6 expression in the prostate cancer disparity among African American men
-
批准号:10544740
-
项目类别:
-
资助金额:$18.33万
-
财政年份:2022
-
负责人:JIANMING XU
-
依托单位:
The primary role of low NCOA6 expression in the prostate cancer disparity among African American men
-
批准号:10356340
-
项目类别:
-
资助金额:$22.44万
-
财政年份:2022
-
负责人:JIANMING XU
-
依托单位:
Core B (Animal Component)
-
批准号:10153758
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2018
-
负责人:JIANMING XU
-
依托单位:
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer
-
批准号:9030156
-
项目类别:
-
资助金额:$37.4万
-
财政年份:2015
-
负责人:JIANMING XU
-
依托单位:
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer
-
批准号:10057354
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2015
-
负责人:JIANMING XU
-
依托单位:
CORE--ANIMAL
-
批准号:7477178
-
项目类别:
-
资助金额:$25.49万
-
财政年份:2007
-
负责人:JIANMING XU
-
依托单位:
The Role of SRC-1 in Breast Cancer
-
批准号:7687978
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
The Role of SRC-1 in Breast Cancer
-
批准号:7033788
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
The Role of SRC-1 in Breast Cancer
-
批准号:7902052
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
CORE--ANIMAL
-
批准号:7215502
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
The Role of SRC-1 in Breast Cancer
-
批准号:7282423
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
The Role of SRC-1 in Breast Cancer
-
批准号:9037601
-
项目类别:
-
资助金额:$26.97万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
The Role of SRC-1 in Breast Cancer
-
批准号:8457014
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
The Role of SRC-1 in Breast Cancer
-
批准号:7472593
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
The Role of SRC-1 in Breast Cancer
-
批准号:7909371
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
The Role of SRC-1 in Breast Cancer
-
批准号:8295580
-
项目类别:
-
资助金额:$26.97万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
The Role of SRC-1 in Breast Cancer
-
批准号:8641325
-
项目类别:
-
资助金额:$26.16万
-
财政年份:2006
-
负责人:JIANMING XU
-
依托单位:
Role of AIB3 in Mammary Gland and Breast Cancer
-
批准号:6969952
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2005
-
负责人:JIANMING XU
-
依托单位:
Role of AIB3 in Mammary Gland and Breast Cancer
-
批准号:7092206
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2005
-
负责人:JIANMING XU
-
依托单位:
Role of AIB3 in Mammary Gland and Breast Cancer
-
批准号:7229067
-
项目类别:
-
资助金额:$28.09万
-
财政年份:2005
-
负责人:JIANMING XU
-
依托单位:
海外基金